| Metric | Value (₹ Cr) | Q4 FY26 | Q1 FY26 |
|---|---|---|---|
| Revenue | 276.33 | 39.9% | 120.7% |
| Total Income | 276.55 | 39.4% | 120.4% |
| Expenditure | 257.26 | 40.9% | 119.0% |
| PBT | 19.29 | 23.0% | 140.8% |
| Net Profit | 15.04 | 24.3% | 130.7% |
| OPM | 8.18% | 2.01pp | 1.10pp |
| NPM | 5.44% | 0.66pp | 0.24pp |
| EPS | 4.85 | 24.4% | 59.7% |
Record Profit, Crumbling Margins—FY27 Target Slashed
Revenue and PAT surged 120%+ on the FMCG pivot, but profitability margins compressed sharply. Management downgraded full-year guidance by 100 basis points, signaling execution risk on cost normalization.
₹276.3 Cr
+120.6% YoY
₹15.0 Cr
+130.7% YoY
5.4%
vs 7% target, −160 bps miss
8.18%
−110 bps YoY, −101 bps QoQ
The headline earnings look phenomenal—revenue up 120%, profit dollars up 130%—but the story flips when you look at what those dollars represent. Profit margins compressed sharply across the board. EBITDA margin fell to 8.18% from 9.28% a year ago. PAT landed at just 5.4%, overshooting the 7% full-year target by 160 basis points. Management's response: downgrade the full-year PAT margin guidance from 7% to 6%, a 100 basis point step-down. The quarter validated the FMCG pivot strategy, but it exposed execution risk on cost normalization.
What the numbers say
The culprit is geopolitical commodity volatility. LABSA, dyes, chemicals, polypropylene, and fuel spiked through Q1 due to ongoing crude oil tension, and management acknowledged they haven't yet recovered pricing power fast enough to offset input cost inflation. The FMCG segment's EBITDA margin did improve 65 basis points year-on-year to 8.55%, showing that the strategic pivot toward high-margin consumer-goods manufacturing is working operationally. But consolidated margins were dragged down by cost pressures and the underperformance of the legacy textile business, which management expects to recover by Q3 but has not yet proven.
On the positive side, the FMCG revenue mix has shifted to 90.6% of total revenue from 83% in FY26, validating the pivot away from textiles. Capacity utilization sits at 50–55%, with management expecting an additional 25–30% utilization ramp by FY28. If that ramp materializes, existing capacity is sufficient to hit the company's ₹1,000 Cr revenue target by FY28 without major incremental capex.
Q1 is the strongest quarter in company history
Revenue ₹276.3 Cr (+120.6% YoY), PAT ₹15.0 Cr (+130.7% YoY) confirmed
Supported
FMCG segment EBITDA margin improved to 8.55%
8.55% Q1 FY27 vs 7.90% Q1 FY26: +65 bps YoY growth
Supported
Consolidated margin moderation due to geopolitical headwinds
EBITDA 8.18% vs 9.28% Q1 FY26 (−110 bps YoY) and 10.19% Q4 FY26. FMCG margin up; consolidated dragged by costs
Supported
FY27 profitability target is ~6% PAT margin
Prior guidance was 7% by FY27; new guidance 6% for FY27. Q1 delivered 5.4%, below both targets
Overstated / Downgraded
What changed on this call
Three material shifts: First, FY27 PAT margin guidance was cut 100 basis points from 7% to 6%, with management framing Q1's 5.4% as a temporary cost impact and Q3–Q4 as the recovery window. Second, the FMCG strategic pivot is now explicit and dominant—90.6% of revenue in Q1—and management reaffirmed the target to drive this to 90–92% in the long term, validating the exit from textiles. Third, the ₹1,000 Cr FY28 revenue target remains unchanged despite the margin miss, and management emphasized that existing installed capacity (20,840 MT/month) is sufficient to achieve this target without significant additional capex.
How the market read it
The stock fell 1.01% on day 1 post-result (delivery 72%), a lukewarm reception to the headline growth. The stock trades at ₹377, which is 87% above its 52-week low of ₹201 but only 4% below its all-time high of ₹394. The Relative Strength Index sits at 77.1—technically overbought—and rising volume suggests possible profit-taking near the highs. Institutional ownership is minimal (FII 0%, DII 3.95%), meaning this is a promoter-and-retail story. Promoter ownership stands at 69.66%, and the thin institutional float amplifies volatility. The day-1 decline despite blowout revenue growth suggests the market was already pricing in the FMCG expansion and remains skeptical of near-term margin recovery.
Record 120% revenue growth validates FMCG pivot strategy
FMCG segment EBITDA margin expanding (+65 bps YoY)
Capacity additions on schedule (Roorkee +1,700 MT, Guwahati ramping)
200+ customer base with long-term contracts and quarterly planning
PAT margin 5.4% vs 7% target—160 bps miss on Q1 already
FY27 PAT margin guidance slashed 100 bps (7%→6%)
Consolidated EBITDA margin down 110 bps YoY and 101 bps QoQ
Geopolitical cost headwinds unproven to normalize by Q3–Q4
Textile business recovery promised by Q3 with no recovery plan disclosed
Margin recovery timing and cost normalization execution
HIGHFY27 PAT margin target already downgraded 100 bps (7%→6%). Q1 delivered 5.4%, requiring Q2–Q4 average >6% for full-year 6%. If cost pressures persist beyond Q3, the target will slip further and call into question management's pricing power.
Input cost volatility (crude-linked: LABSA, dyes, PP, fuel)
HIGHGeopolitical tension is structural, not temporary. No hedging strategy disclosed. Textile segment hit hardest; FMCG also exposed. Consolidated EBITDA margin fell 110 bps YoY despite strong revenue growth. Pricing pass-through to customers is not immediate.
Capacity utilization ramp execution (50–55% to 75–85%)
MEDIUMMargin recovery by FY28 depends entirely on utilization ramp and customer additions to fill new capacity. Management confident on traction but provides no customer pipeline detail. Any slowdown in B2B demand will jeopardize profitability targets.
B2B customer concentration and revenue dependency
MEDIUM100% of revenue is B2B to unnamed OEM customers. While 200+ customer base is claimed, concentration in top 3–5 likely high. Loss of a major customer could derail growth and utilization ramp.
Textile business underperformance and lack of recovery plan
LOWTextile segment underperformed Q1 (~10% of revenue) due to cost pressures. Management expects recovery by Q3 with no detail on cost actions or demand visibility. Given commodity exposure, recovery is not assured.
1 · Q2 PAT margin and cost trajectory
Q1 delivered 5.4%; Q2 must show improvement toward 6% for FY27 full-year credibility. Watch for evidence of LABSA, dye, and fuel cost normalization. If Q2 margin remains <5.5%, the 6% full-year target is at risk.
2 · Capacity utilization ramp and customer additions
Roorkee and Guwahati expansions should drive utilization from 50–55% toward 60%+ by Q2–Q3. Management guidance of 25–30% incremental utilization by FY28 is the key lever for margin recovery. Monitor for customer announcements or quarterly volume trends.
3 · Textile recovery timing and strategy
Management promised textile recovery by Q3. If not evident in Q3 results (and associated cost actions disclosed), the business case for retention weakens and pressure for divestment or restructuring will mount.
A.K. Spintex delivered the growth the strategy promised—120% revenue expansion on the FMCG pivot is real, and segment margins are improving operationally. But profitability execution is the question, not revenue. Management has already downgraded the margin target once, and Q1 came in 160 basis points below the prior goal. Near-term cost recovery is unproven, and the technical setup (overbought RSI, thin institutional ownership, day-1 decline) suggests limited enthusiasm at current levels.
This is a medium-term hold, not a near-term buy. Execution on capacity utilization and margin recovery is the single most important variable for the next two quarters. If Q2–Q3 show cost normalization and margin stabilization at 6%+, the ₹1,000 Cr FY28 target becomes credible and the stock likely re-rates higher. If margins remain below 5.5%, conviction shifts to caution. The number to track: organic PAT margin ex-capacity excuses.
Record growth masks margin squeeze from commodity volatility
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
INR 1,000 Cr FY28 target reaffirmed. FY27 margin guidance downgraded 100 bps (7%→6%). Mixed track record on timing.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Record Q1 revenue/profit growth (+120%/+130%) validates FMCG pivot strategy. However, margin compression (EBITDA -101 bps QoQ to 8.2%, PAT 5.4% vs 7% target) and FY27 profitability downgrade (6% vs prior 7% guide) reveal execution risk on cost normalization. Near-term headwinds unproven temporary.
₹276.3 Cr
Revenue · +120.6% YoY₹15 Cr
Reported PAT · +130.7% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Q1 strongest quarter in Sunrakshakk history
METRevenue ₹276.3 Cr (+120.6% YoY), PAT ₹15.0 Cr (+130.7% YoY) confirmed
FMCG segment EBITDA margin improved to 8.55%
MET8.55% Q1 FY27 vs 7.90% Q1 FY26: +65 bps YoY growth evident
Consolidated margin moderation due to geopolitical headwinds
METEBITDA 8.18% vs 9.28% Q1 FY26 (YoY) and 10.19% Q4 FY26. FMCG margin up YoY, consolidated dragged by costs.
Expect FY27 profitability at 6% level
OVERSTATEDPrior guidance 7% by FY27; new guidance 6% for FY27. Q1 delivered 5.4%, below both targets.
Earnings quality
What changed since the last call
FY27 PAT margin downgraded
DowngradePrior 7% by FY27 → new 6% for FY27. Management frames as Q1 cost impact, expects recovery H2. 100 bps step-down.
FMCG mix shift reaffirmed
NeutralFMCG now 90.6% of revenue (up from 83% FY26). Strategic pivot on track; no change to long-term 90-92% target.
INR 1,000 Cr FY28 target unchanged
NeutralReaffirmed despite Q1 margin miss. Management confident existing capacity sufficient; no CapEx needed beyond 2024 plans.
The Q&A
Analysts pressed on margin recovery timing, cost normalization, textile outlook, and M&A plans. Management acknowledged headwinds but minimized as temporary, defended textile as manageable, avoided specific cost recovery dates. Tone professional but soft on near-term commitments.
Input costs, geopolitical headwinds — Shravan Modi, Syndicate Family Office
AnsweredDyes, chemicals, LABSA, fuel, PP spiked due to geopolitical tension. Textile hit hardest. Expect normalization by Q3-Q4.
Revenue and profitability guidance — Mudit, individual investor
AnsweredFY27: INR 900-1,000 Cr revenue, 6% PAT margin (down from 7% prior). FY28: 15-20% growth, 0.75-1% margin improvement.
Capacity utilization headroom — Muskan Patel, JK Investments
AnsweredCurrently 50-55% utilization. Expect 25-30% additional capacity utilization by FY28. Profit margin improvement tied to volume scale.
Textile business sustainability — Mudit, individual investor
PartialQ1 numbers weak but internally re-evaluated. Expect recovery by Q3. No demerger plans; textile small portion of revenue.
EBITDA margin sustainability — Aniket Redkar, individual investor
PartialCurrent quarter will improve. Targeting 7% PAT by FY28; EBITDA will rise 2-2.5% from current level via capacity optimization.
FY28 1,000 Cr target confidence — Aniket Redkar, individual investor
AnsweredVery optimistic; numbers very encouraging. Will close FY27 at INR 900-1,000 Cr. FY28 target reaffirmed and achievable.
Segment growth drivers — Krisha Modi, individual investor
AnsweredFood business and soap segment will have higher contribution next 2 years. Both newly ramping, high-growth trajectory.
M&A and new products — Mansavi Mukerjee, Oracle Investment
AnsweredNo current acquisition discussions. Open to lucrative proposals. Developing new food products within existing capacity; some may need CapEx.
Guidance
FY27: INR 900-1,000 Cr revenue
HighQ1 at ₹276 Cr; FY27 implies mid-to-high 200s per quarter average. Range anchored and credible.
FY28: 15-20% growth from FY27
MediumImplies FY28 ₹1,035-1,200 Cr. INR 1,000 Cr target emphasized as achievable with existing capacity only.
Revenue CAGR FY25-FY29: 32-35%
MediumRequires disciplined capacity utilization ramp from 50-55% to 75-85%+ by FY28.
FY27: ~6% PAT margin
MediumDowngraded from prior 7% target. Q1 at 5.4%; Q2-Q4 must average >6% for full-year 6%. Cost recovery timing uncertain.
FY28: 0.75-1% PAT margin improvement
MediumImplies FY28 PAT margin 6.75-7%. Dependent on input cost normalization and utilization gains.
EBITDA margin by FY28: +2-2.5% from Q1
MediumQ1 EBITDA 8.18%; +2-2.5% implies 10.2-10.7% by FY28. Requires cost stabilization and scale benefits.
No major CapEx next 1-1.5 years
HighMost capacity expansion completed (Roorkee Q4-Q1, Guwahati ramp-up). Focus now on utilization, not expansion.
Risks the call surfaced
Input cost volatility
HighLABSA, dyes, chemicals, PP, fuel prices spiked Q1. Geopolitical tension driving volatility. Textile hit hardest; FMCG also exposed. Management cites normalization hope but no hedge disclosed.
Capacity utilization
MediumRecent capacity additions (Roorkee Q1, Guwahati ongoing) must ramp utilization 25-30% by FY28 to hit margin targets. No detail on demand trajectory or customer commitments to fill new capacity.
Margin recovery timing
HighPAT margin target downgraded 100 bps (7% → 6% for FY27). Q1 delivered 5.4%, requiring Q2-Q4 average >6%. Cost normalization and utilization gains must materialize on schedule.
Textile business underperformance
LowTextile segment underperformed Q1 (~10% of revenue). Exposed to dyes, chemicals, crude-linked costs. Management confident on Q3 recovery but no numbers provided.
B2B customer concentration
Medium90% of revenue is B2B manufacturing to unnamed customers (management withheld names). Customer base stated 200+, but concentration in top 3-5 likely high. Loss of major customer risks growth.
Management
Score 7/10. Transparent on cost headwinds with specifics (LABSA, dyes, PP, fuel). Acknowledged margin compression; did not hide Q1 profitability miss. Some defensive tone on textile recovery (promised Q3 improvement without details). Professional and clear on strategy. FMCG pivot delivered (90.6% revenue mix vs 83% prior); new capacity commissioned on schedule (Roorkee +1,700 MT, Guwahati ramp). But margin compression (EBITDA -110 bps YoY, -101 bps QoQ) and FY27 downgrade (7%→6%) signal execution challenges on cost management. Mixed track record.
1 · Q2-Q3 FY27
Geopolitical tension easing, crude/LABSA cost normalization expected
2 · Q2-Q4 FY27
Roorkee/Guwahati capacity ramp-up, utilization expanding from 50-55% toward target
3 · FY28
INR 1,000 Cr revenue milestone, 7% PAT margin target
Near-term headwinds unproven temporary.